2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9980):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W777286
    rac-Lenalidomide-13C5
    rac Lenalidomide-13C5 is a 13C-labeled rac Lenalidomide.
    rac-Lenalidomide-<sup>13</sup>C<sub>5</sub>
  • HY-W725874
    1-Cyclopentyl-4-nitrosopiperazine-d9
    1-Cyclopentyl-4-nitrosopiperazine-d9 is the deuterium labeled 1-Cyclopentyl-4-nitrosopiperazine (HY-W613767).
    1-Cyclopentyl-4-nitrosopiperazine-d<sub>9</sub>
  • HY-W004392S
    2-Ethylhexyl bromide-d17
    2-Ethylhexyl bromide-d17 is the deuterium labeled 2-Ethylhexyl bromide.
    2-Ethylhexyl bromide-d<sub>17</sub>
  • HY-50898S1
    Lapatinib-d7 dihydrochloride
    Lapatinib-d7 dihydrochloride is the deuterium labeled Lapatinib dihydrochloride. Lapatinib (GW572016) dihydrochloride is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively.
    Lapatinib-d<sub>7</sub> dihydrochloride
  • HY-N0187S
    4-Methylumbelliferone-13C4
    4-Methylumbelliferone-13C4 (Hymecromone-13C4) is the 13C-labeled 4-Methylumbelliferone (HY-N0187). 4-Methylumbelliferone is a hyaluronic acid biosynthesis inhibitor with antitumoral and antimetastatic effects.
    4-Methylumbelliferone-<sup>13</sup>C<sub>4</sub>
  • HY-W766967
    3,5-Di-O-p-chlorobenzoyl a,b-Floxuridine-13C,15N2
    3,5-Di-O-p-chlorobenzoyl a,b-Floxuridine-13C,15N2 is the 13C- and 15N-labeled 3,5-Di-O-p-chlorobenzoyl a,b-Floxuridine.
    3,5-Di-O-p-chlorobenzoyl a,b-Floxuridine-<sup>13</sup>C,<sup>15</sup>N<sub>2</sub>
  • HY-W654293
    6-Nitro-1-pyrenol-d8
    6-Nitro-1-pyrenol-d8 is the deuterium labeled 6-Hydroxy-1-nitropyrene (HY-W588307).
    6-Nitro-1-pyrenol-d<sub>8</sub>
  • HY-W702539
    1,4-Bis(bromomethyl)benzene-d4
    1,4-Bis(bromomethyl)benzene-d4 is the deuterium labeled 1,4-Bis(bromomethyl)benzene (HY-41341).
    1,4-Bis(bromomethyl)benzene-d<sub>4</sub>
  • HY-104077S1
    Remdesivir-d4
    Remdesivir-d4 (GS-5734-d4) is deuterium labeled Remdesivir (HY-104077). Remdesivir (GS-5734) is a nucleoside analogue with effective antiviral activity. Remdesivir can inhibit the synthesis of viral DNA or RNA. Remdesivir can be used for the research of infection, such as SARS-CoV and MHV infection.
    Remdesivir-d<sub>4</sub>
  • HY-32067AS
    Aceclidine-d3 hydrochloride
    Aceclidine-d3 hydrochloride is a deuterated version of Aceclidine (HY-32067). Aceclidine is a modulator of the M3 muscarinic acetylcholine receptor.
    Aceclidine-d<sub>3</sub> hydrochloride
  • HY-13635S
    Finasteride-d9
    		99.13%
    Finasteride-d9 is deuterium labeled Finasteride. Finasteride (MK-906) is a potent and competitive 5α-reductase inhibitor, with an IC50 of 4.2 nM for type II 5α-reductase. Finasteride has approximately a 100-fold greater affinity for type II 5α-reductase enzyme than for the type I enzyme. Finasteride can be used for the research of benign prostatic hyperplasia (BPH) and androgenic alopecia.
    Finasteride-d<sub>9</sub>
  • HY-B0973S
    Dibenzothiophene-d8
    Dibenzothiophene-d8 is the deuterium labeled Dibenzothiophene (HY-B0973). Dibenzothiophene is an orally active and a noncompetitive CYP1A inhibitor. Dibenzothiophene inhibits CYP1A-mediated EROD activity with Km of 0.592 μM. Dibenzothiophene interacts with the AHR pathway. Dibenzothiophene enhances the embryotoxicity of β-naphthoflavone (HY-114740). Dibenzothiophene shows acute toxicity in mice. Dibenzothiophene is mainly used for the study of the mechanism of developmental toxicity in organisms.
    Dibenzothiophene-d<sub>8</sub>
  • HY-113015S
    Stearoylethanolamide-d3
    Stearoylethanolamide-d3 (Ceamid-d3) is deuterium labeled Stearoylethanolamide. Stearoylethanolamide is an endocannabinoid-like compound with pro-apoptotic activity.
    Stearoylethanolamide-d<sub>3</sub>
  • HY-14648S2
    Dexamethasone-d4
    		98.93%
    Dexamethasone-d4 is deuterium labeled Dexamethasone. Dexamethasone (Hexadecadrol) is a glucocorticoid receptor agonist. Dexamethasone also significantly decreases CD11b, CD18, and CD62L expression on neutrophils, and CD11b and CD18 expression on monocytes. Dexamethasone is highly effective in the control of COVID-19 infection. Dexamethasone inhibits production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.
    Dexamethasone-d<sub>4</sub>
  • HY-146943S
    24:0 L-carnitine-d4
    		99.0%
    24:0 L-carnitine-d4 is deuterium labeled 24:0 L-carnitine.
    24:0 L-carnitine-d<sub>4</sub>
  • HY-W007035S
    H-Val-Ala-OH-13C5,15N TFA
    H-Val-Ala-OH-13C5,15N (Valyl-alanine-13C5,15N) TFA is the 13C- and 15N-labeled H-Val-Ala-OH (HY-W007035). H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste.
    H-Val-Ala-OH-<sup>13</sup>C<sub>5</sub>,<sup>15</sup>N TFA
  • HY-146875S
    1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol-d31 ammonium
    		≥99%
    1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol-d31 (ammonium) is deuterium labeled 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol (ammonium).
    1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol-d<sub>31</sub> ammonium
  • HY-142475S
    N,N'-Bis(2,6-dimethylphenyl)-1,4-piperazinediacetamide-d8
    N,N'-Bis(2,6-dimethylphenyl)-1,4-piperazinediacetamide-d8 is the deuterium labeled N,N'-Bis(2,6-dimethylphenyl)-1,4-piperazinediacetamide.
    N,N'-Bis(2,6-dimethylphenyl)-1,4-piperazinediacetamide-d<sub>8</sub>
  • HY-W738533
    Pioglitazone-d4 hydrochloride
    Pioglitazone-d4 hydrochloride (U 72107A-d4; AD 4833-d4) is the deuterium labeled Pioglitazone hydrochloride (HY-14601). Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
    Pioglitazone-d<sub>4</sub> hydrochloride
  • HY-I0392AS
    (S)-Cinacalcet-d3 hydrochloride
    (S)-Cinacalcet-d3 (hydrochloride) is the deuterium labeled (S)-Cinacalcet.
    (S)-Cinacalcet-d<sub>3</sub> hydrochloride